Best Puerto Rico Grants for Nonprofits

The Fy 2026 Drug Court Training and Technical Assistance Cooperative Agreement, led by ONDCP, aims to enhance access to evidence-based addiction treatments through drug courts. This initiative focuses on educating and training stakeholders to implement effective treatment strategies for individuals with addiction, particularly those facing co-occurring mental health conditions. By reducing criminal justice costs and recidivism rates, the program supports the President's priorities for long-term recovery and improved public health.

This research study, funded by the Bureau of Consular Affairs, aims to explore the effects of international parental child abduction (IPCA) on affected children and their left-behind parents. It seeks to identify the short- and long-term impacts across various domains such as mental health, child development, and legal systems. The study will also pinpoint gaps in support for these families and propose actionable solutions to enhance their well-being and community integration.

The Program for Investment in Microentrepreneurs (PRIME) is an initiative by the Small Business Administration (SBA) aimed at empowering disadvantaged entrepreneurs through training and technical assistance. The program also supports microenterprise development organizations in building capacity and researching best practices for effective assistance. By fostering entrepreneurship, PRIME contributes to economic growth and enhances opportunities for underserved communities.

The OVW Fiscal Year 2026 Consolidated Grant Program aims to support community-based initiatives that assist children and youth impacted by domestic violence, dating violence, sexual assault, and stalking. It also focuses on engaging men and youth in prevention efforts. Eligible applicants can develop or expand strategies for prevention, intervention, and treatment, addressing the needs of affected individuals aged 0-24. Applications are due by September 10, 2026.

The grant titled 'Enhancing Biotechnology Market Opportunities for U.S. Exporters and American Farmers' aims to expand market access for U.S. agricultural biotechnology products by addressing barriers in international trade. It focuses on engaging trading partners through seminars and workshops to foster dialogue on agricultural biotechnology. With a significant export value of over $51 billion, the initiative supports American farmers and promotes sustainable agricultural practices by encouraging innovation and collaboration in biotechnology development.

The NIOSH Centers for Agriculture, Forestry, and Fishing Safety and Health provide critical support to enhance worker safety and health in the vital AgFF sector. With a focus on high-quality interdisciplinary research, these centers aim to translate scientific findings into practical solutions, improve health outcomes, and engage with partners to promote best practices. By addressing health hazards and improving data coordination, these centers strive for a meaningful impact on the well-being of AgFF workers across the nation.

The NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54) aims to enhance the safety and well-being of youth in the agriculture sector. This initiative will conduct vital research, improve data collection, and implement effective interventions to mitigate risks faced by young workers. By collaborating with various stakeholders, the center seeks to translate scientific findings into practical solutions that promote healthier working environments for children in agriculture, forestry, and fishing industries.

The High-End Instrumentation (HEI) Grant Program, offered by the NIH, invites applications for purchasing or upgrading high-end, specialized instruments, with a minimum award of $750,001 and a maximum of $2,000,000. This program supports NIH investigators aiming to enhance their research capabilities through advanced technologies such as mass spectrometers and electron microscopes. Applications must be submitted by 5:00 pm local time of the applicant organization.

The NIH is seeking innovative computational approaches to enhance the curation of biomedical research assets at scale. This initiative aims to accelerate access to secure datasets and computational models, facilitating transformative discoveries in biomedical science. Key deadlines for applications range from January 2025 to January 2027, covering standard, renewal, and AIDS-related grants. Applicants are encouraged to submit Letters of Intent 30 days prior to application deadlines to ensure a streamlined review process.

The DoW Bone Marrow Failure Investigator-Initiated Research Award supports innovative research aimed at advancing the understanding and treatment of bone marrow failure. This funding opportunity encourages applications for translational and clinical studies, requiring preliminary data to strengthen proposals. Unique features include the ability for a partnering Principal Investigator to contribute to the research, thereby fostering collaboration while maintaining a focus on significant advancements in patient care.

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program, funded by the NIH, aims to enhance the biomedical research landscape by supporting resource-limited organizations. It targets domestic institutions with limited research resources and few doctoral students in biomedical fields, promoting broader participation in research and boosting administrative capacities for sponsored programs. Applications are due by 5:00 PM local time of the applicant organization, ensuring timely submissions.

This grant opportunity from the NIH aims to enhance mechanistic research on precision probiotic therapies through a biphasic R61/R33 award mechanism. It encourages innovative studies to identify specific biological factors influencing probiotic responses, thereby improving clinical outcomes. The program supports up to five years of research, with the initial phase focused on discovering unique host characteristics and the second phase assessing improvements in probiotic efficacy through rigorous studies.

This funding opportunity aims to advance mechanistic research for precision probiotic therapies. It invites R33 applications focused on characterizing individual differences in probiotic responses, identifying responder subgroups, and enhancing clinical outcomes. The goal is to develop strategies addressing barriers to effective probiotic use, accounting for human variability. Proposals should include innovative studies using animal models or human subjects, supported by preliminary data to test biological patterns and their effects on health outcomes.

The DoW Bone Marrow Failure Idea Development Award supports innovative, high-impact research aimed at understanding and curing bone marrow failure diseases. This grant is available to both Established Investigators and Early-Career Investigators, with no preliminary data required for applications. Reviewers assess proposals based on specific criteria tailored to the investigator's career stage. The focus is on achieving interpretable results that contribute significantly to the field.

The DoW Rare Cancers Concept Award for FY26 promotes groundbreaking ideas in rare cancer research. This award encourages innovative applications that explore novel courses of investigation without requiring preliminary data. Unique to this program is the prohibition against mentioning the Principal Investigator or collaborators in the proposal materials, ensuring an unbiased review process. This funding opportunity aims to advance scientific discovery in the rare cancer domain.

The CCRP Initiative invites applications for basic research on chemical threats affecting the nervous system, including chemical warfare agents and toxic industrial chemicals. This funding aims to elucidate toxicity mechanisms, explore new toxic exposure manifestations, and identify targets for therapeutic development. Proposals should generate data relevant to understanding these toxic threats, with applications due by 5 PM local time. Optional Letters of Intent are encouraged 30 days prior to the proposal deadline.

The NIH Independent Scientist Award (K02) supports promising scientists in their research endeavors, providing salary and protected time for three to five years. This award is designed for newly independent scientists who can demonstrate the necessity for focused research to advance their careers. The program specifically targets basic experimental studies involving human participants, aligning with NIH's clinical trial definitions and aims to foster significant contributions to various scientific fields.

Our Mission

We strengthen our community for current and future generations by helping people make a difference in the lives of all.

We believe in our community’s lasting goodness. In fact, making sure our community is always a special place for us to live is why we’re here.

Scholarships

Through the generosity of our donors, we have more than $2 million in scholarships available in 2025 to students from more than 60 high schools. We offer scholarships to high school seniors, college and nontraditional students, and K-12 art and music camps and lessons.

The Academy Martial Arts Leadership Scholarship

Background

The Academy Martial Arts Leadership has been serving families in the Fox Cities since 1995. As the founders/owners, Jeff & Amanda Denu have been passionate about making our community stronger one Black Belt at a time teaching martial arts, while reinforcing respect, self-discipline, integrity, and excellence. Their passion with community involvement and creating a positive learning environment inspires others to be their personal best, and to make a difference every day.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The Regional Conservation Partnership Program (RCPP) Classic for FY 2026 encourages collaboration between the NRCS and partners to address critical natural resource concerns through innovative projects. By co-investing with partners, the program aims to enhance conservation efforts on farms and private lands, ensuring equitable access to NRCS services. Selected proposals will be based on their potential impact and effective partnership management, ultimately improving environmental outcomes across designated Critical Conservation Areas.

The Foreign Language Study Grants provide funding up to $5,000 for Harvard graduate students in doctoral programs to participate in intensive language programs abroad. The grants support students after their G1, G2, or G3 years, emphasizing the necessity of the language for their research. Recipients must conduct their studies outside the U.S., ensuring a minimum duration of six weeks for the language program.

The Aging Research Dissertation Awards aim to enhance diversity in the scientific workforce by funding research on aging and related health conditions. The program encourages applicants from underrepresented backgrounds to apply for dissertation awards that align with the National Institutes of Health's strategic priorities. Key deadlines for applications include February 16, June 16, and October 16 for the years 2024 through 2026.

The FY26 Tick-Borne Disease Research Program (TBDRP) Idea Development Award aims to fund innovative research that enhances understanding and treatment of Lyme disease and other tick-borne diseases. The program encourages creative approaches that challenge existing paradigms and fosters impactful discoveries. A special career development option is available for early-career investigators, offering mentorship and a tailored review process to support significant research advancements.

The FY26 Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award aims to foster innovative therapeutic and diagnostic research for Lyme disease and other tick-borne conditions. This award supports early-stage drug discovery and evaluation studies, as well as novel diagnostic methods that can be seamlessly implemented in clinical environments, ultimately enhancing patient care and quality of life.

The Miniaturization and Automation of Tissue Chip Systems (MATChS) initiative supports the development of advanced technologies for automated tissue chip platforms. This funding opportunity, provided by the NIH, aims to enhance drug development and biomedical research by enabling high-throughput automated measures and online data analysis. Successful applications will demonstrate collaboration with NIH staff to achieve project milestones and pathways to commercialize these innovative systems, ultimately increasing the accessibility of miniaturized solutions in research.

The National Institute of Dental and Craniofacial Research (NIDCR) is inviting innovative research applications on the causal relationships between human behaviors and oral-systemic health impacts, particularly for people with chronic conditions. This funding opportunity encourages the exploration of biological, environmental, and psychosocial factors contributing to health outcomes. Projects should aim for translation into clinical trials to manage dental and craniofacial conditions effectively. Collaboration among diverse health experts is strongly encouraged.

The Limited Competition Small Grant Program supports NCATS CTSA Program KL2 scholars, enhancing their transition to independent academic translational scientists. This R03 funding facilitates various research projects, including pilot studies and methodology development, aimed at generating preliminary data for future R01 applications. The program is designed for short-term projects utilizing limited resources, promoting innovative research in clinical and translational science.